Blood transfusions in organ transplant patients: Mechanisms of sensitization and implications for prevention

American Journal of Transplantation

Volumn 11, Issue 9, 2011, Pages 1785-1791

  Scornik, J C ^a   Meier Kriesche, H U ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

HLA antibodies; organ transplants; sensitization; transfusions

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA ANTIBODY;

BLOOD TRANSFUSION; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; GROUPS BY AGE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LEUKOPENIA; NEPHRECTOMY; ORGAN TRANSPLANTATION; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIZATION;

AUTOANTIBODIES; BLOOD TRANSFUSION; FEMALE; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; PREGNANCY; PREGNANCY COMPLICATIONS; RISK ASSESSMENT;

EID: 80052262783     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03705.x     Document Type: Review

References (46)

1. Taube DH, Williams DG, Cameron JS, et al,. Renal transplantation after removal and prevention of re-synthesis of HLA antibodies. Lancet 1984; 1: 824-826. (Pubitemid 14174284)
2. Burns JM, Cornell LD, Perry DK, et al,. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008; 8: 2684-2694.
3. Trucco M, dePetris S, Garrotta G, Ceppellini R,. Quantitative analysis of cell surface HLA structure by means of monoclonal antibodies. Hum Immunol 1980; 3: 233-243. (Pubitemid 12234628)
4. Brown G, Biberfeld P, Christensson B, Mason DY,. The distribution of HLA on human lymphoid, bone marrow and peripheral blood cells. Eur J Immunol 1979; 9: 272-275. (Pubitemid 9205189)
5. Ng PK, Li G, Chi KM, et al,. Quantitative measurement of monocyte HLA-DR expression in the identification of early-onset neonatal infection. Biol Neonate 2006; 89: 75-81. (Pubitemid 43254161)
6. Everett ET, Kao KJ, Scornik JC,. Class I HLA molecules on human erythrocytes: Quantitation and transfusion effects. Transplantation 1987; 44: 123-129.
7. Salama A, Mueller-Eckhardt G, Strauss BE, Mueller-Eckhardt C,. HLA-B7 on human red blood cells: Improved detection by a radioactive anti-IgG test. Tissue Antigens 1982; 19: 183-188. (Pubitemid 12111468)
8. Everett ET, Scornik JC, Davis G, Kao KJ,. Induction of erythrocyte HLA expression during interferon treatment and HIV infection. Hum Immunol 1990; 29: 14-22. (Pubitemid 20250603)
9. Pfaff WW, Fennell RS, Howard RJ, et al,. Planned random blood transfusions in preparation for transplantation. Transplantation 1984; 38: 701-703.
10. Salvatierra O, Vincenti F, Amend W, et al,. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980; 192: 543-552. (Pubitemid 11225438)
11. Siemionow M, Agaoglu G,. Role of blood transfusion in transplantation: A review. J Reconstr Microsurg 2005; 21: 555-563. (Pubitemid 41739393)
12. Croce MA, Tolley EA, Claridge JA, Fabian TC,. Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 2005; 59: 19-24. (Pubitemid 41271633)
13. Palmieri TL, Caruso DM, Foster KN, et al,. Effect of blood transfusion on outcome after major burn injury: A multicenter study. Crit Care Med 2006; 34: 1602-1607. (Pubitemid 43810037)
14. Marti HP, Henschkowski J, Laux G, et al,. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era. Transpl Int 2006; 19: 19-26.
15. Aalten J, Bemelman FJ, van den Berg-Loonen EM, et al,. Pre-kidney transplant blood transfusions do not improve transplantation outcome. Nephrol Dial Transplant 2009; 24: 2559-2566.
16. Opelz G, Graver B, Mickey MR, Terasaki PI,. Lymphocytotoxic antibody response to transfusions in potential kidney transplant recipients. Transplantation 1981; 32: 177-183. (Pubitemid 11004244)
17. Scornik JC, Pfaff WW, Howard RJ, et al,. Increased antibody responsiveness to blood transfusions in pediatric patients. Transplantation 1994; 58: 1361-1365.
18. Karpinski M, Pochinco D, Dembinski I, et al,. Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates. J Am Soc Nephrol 2004; 15: 818-824. (Pubitemid 38294813)
19. Norman DJ, Barry JM, Wetzsteon PJ,. Successful cadaver kidney transplantation in patients highly sensitized by blood transfusions. Transplantation 1985; 39: 253-255.
20. Triulzi DJ, Kleinman S, Kakaiya RM, et al,. The effect of previous pregnancy and transfusions on HLA alloimmunization in blood donors: Implications for a transfusion-related acute lung injury risk induction strategy. Transfusion 2009; 49: 1825-1835.
21. Kakaiya RM, Triulzi DJ, Wright DJ,. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion 2010; 50: 1328-1334.
22. Cusi MG, Martorelli B, Di Genova G, et al,. Age related changes in T cell mediated immune response and effector memory to respiratory syncytial virus (RSV) in healthy subjects. Immun Ageing 2010; 7: 1-8.
23. Kumpati GS, Cook DJ, Blackstone EH, et al,. HLA sensitization in ventricular assist device recipients: Does type of device make a difference? J Thorac Cardiovasc Surg 2004; 127: 1800-1807. (Pubitemid 38725463)
24. Massad MG, Cook DJ, Schmitt SK, et al,. Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg 1997; 64: 1120-1125. (Pubitemid 27497394)
25. Reisner EG, Kostyu DD, Phillips G, Walker C, Dawson DV,. Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens 1987; 30: 161-166. (Pubitemid 17160905)
26. Regan L, Braude PR, Hill DP,. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991; 6: 294-298.
27. Konoeda Y, Terasaki PE, Wakisaka A, et al,. Public determinants of HLA indicated by pregnancy antibodies. Transplantation 1986; 41: 253-259. (Pubitemid 16104707)
28. Rebibou JM, Chabod J, Alcalay D, et al,. Flow cytometric evaluation of pregnancy induced anti-HLA immunization and blood transfusion-induced reactivation. Transplantation 2002; 74: 537-540. (Pubitemid 34977685)
29. Scornik JC, Ireland J, Salomon DR, et al,. Pre-transplant blood transfusions in patients with previous pregnancies. Transplantation 1987; 43: 449-450. (Pubitemid 17044765)
30. Moll S, Pascual M,. Humoral rejection of organ allografts. Am J Transplant 2005; 5: 2611-2618.
31. Scornik JC, Meier-Kriesche H-Y,. HLA sensitization after transplant loss: Timing of antibody detection and implications for prevention. Human Immunol 2011; 72: 398-401.
32. Meier-Kriesche HU, Scornik JC, Susskind B, et al,. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 2009; 88: 23-29.
33. Scornik JC, Ireland JE, Howard RJ, et al,. Sensitization by blood transfusions in previously transplanted patients. Transplantation 1983; 35: 505-506. (Pubitemid 13089929)
34. Slichter SJ,; for the trial to reduce allosensitization to Platelets study group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997; 337: 1861-1869.
35. Scornik JC, Ireland JE, Howard RJ, et al,. Role of regular and leukocyte-free blood transfusions in the generation of broad sensitization. Transplantation 1984; 38: 594-598. (Pubitemid 15183462)
36. Sanfilippo FP, Bollinger RR, MacQuinn JM, et al,. A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion 1985; 25: 116-119. (Pubitemid 15076903)
37. Ohto H, Nomizu OH, Kuroda F, et al,. HLA alloimmunization of surgical patients by transfusion with bedside leukoreduced blood components. Fukushima J Med Sci 2003; 49: 45-54.
38. van de Watering L, Hermans J, Witvliet M, Versteegh M, Brand A,. HLA and RBC immunization after filtered and buffy-coated depleted blood transfusion in cardiac surgery: A randomized controlled trial. Transfusion 2003; 43: 765-771. (Pubitemid 36629122)
39. Ibrahim HN, Ishani A, Foley RN, et al,. Temporal trends in red blood cell transfusion among U.S. dialysis patients, 1992-2005. Am J Kidney Dis 2008; 52: 1115-1121.
40. Pfeffer MA, Burdmann EA, Chen C-Y, et al,. A trial of darbepoyetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361: 2019-2032.
41. Burlingham WJ, Stratta R, Mason B, et al,. Risk factors for sensitization by blood transfusions. Comparison of UW/Madison and UC/San Francisco donor-specific transfusion experience. Transplantation 1989; 47: 140-144. (Pubitemid 19049162)
42. Scornik JC, Salomon DR, Howard RJ, Pfaff WW,. Prevention of transfusion-induced broad sensitization in renal transplant candidates. Transplantation 1989; 47: 617-620. (Pubitemid 19110917)
43. Lagaaij EL, Hennemann PH, Ruigrok M, et al,. Effect of one-HLA-DR-antigen-matched and completely mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701-705. (Pubitemid 19239700)
44. Flye MW, Burton K, Mohanakumar T, et al,. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995; 60: 1395-1401. (Pubitemid 26012669)
45. Cheigh JS, Suthanthiran M, Fotino M, et al,. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. Transplantation 1991; 51: 378-381.
46. Scornik JC, Schold JD, Bucci M, Meier-Kriesche HU,. Effects of blood transfusions given after renal transplantation. Transplantation 2009; 87: 1381-1386.